Veterinary pharma company spun off from Pfizer.


Updates from The Motley Fool

Latest updates on Zoetis from Fool.com.  The Fool has written over 100 articles on Zoetis.
Investing in Pet Healthcare

Here are some tips on investing in a massive industry that’s growing at breakneck speed, with a f...

2 Stocks Bill Ackman Is Dumping

Bill Ackman's Pershing Square Capital Management is dumping these two stocks hand over fist.

8 Top Stocks Billionaires Love

Alphabet, Facebook, Zoetis, Amazon, Priceline, Allergan, and Teva Pharmaceutical are common picks...



Stock Performance

View Interactive ZTS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zoetis.
Current Price: $62.19
Prev Close: $62.01
Open: $62.15
Bid: $62.13
Ask: $62.14
Day's Range: $62.06 - $62.65
52wk Range: $46.86 - $63.84
Volume: 958,236
Avg Vol 2,270,571
Market Cap: $31B
P/E (ttm): 35.84
EPS (ttm): $1.73
Div & Yield: $0.42 (0.7%)

Company Rating

What our community thinks about Zoetis.
CAPS Rating 4 out of 5
 
117 Outperform
5 Underperform
CAPS All Stars
 
28 Outperform
0 Underperform

How do you think Zoetis will perform against the market?



You pick for Zoetis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Juan Ramon Alaix, CEO

75% Approve

Based on 73 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zoetis.

Veterinary pharma company spun off from Pfizer.

  • Exchange: NYSE